Rimmyrah

Medicinal product

(Invented) name

Rimmyrah

Active substance (s)

Ranibizumabas

Strength

10 mg/ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

vartoti į stiklakūnį

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

S01LA04, Ranibizumab

Marketing authorisation holder

QILU PHARMA SPAIN S.L., Ispanija

Date of authorisation

2024-01-05

Date of renewal

Documents

Rimmyrah mokomoji medziaga pacientui.pdf

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(4)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection	1 ml
Ranibizumabas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
112548	98668	1098668	flakonas	0,23 ml N1		Receptinis	EU/1/23/1779/001	Netiekiama	-	2025-12-01	No	-	-
112551	98671	1098671	flakonas	0,23 ml + filtro adata N1		Receptinis	EU/1/23/1779/002	Netiekiama	-	2025-12-01	No	-	-

Stadijos

Data	Stadija
2024-01-05	Registruotas